Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60293-4
Affiliations:
5
Authors:
15
Go to article
Institutions Authors Share
Qilu Hospital of Shandong University, China
14.000000
14.000000
 0.93
Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), CAS, China
1.000000
 0.07
Interested in Genetics?